ArticleDementia and geriatric cognitive disorders extra

Efficacy and Safety of MLC601 in Patients with Mild to Moderate Alzheimer Disease: An Extension 4-Year Follow-Up Study.

Hossein Pakdaman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.